专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

GB202213338D0 Device and method for third low-temperature controllable nuclear fusion 未知
公开(公告)号：GB202213338D0
公开(公告)日：2022-10-26
申请号：GB202213338
申请日：2022-09-13
申请人： CHEN SHIHAO
摘要： The invention discloses a third low-temperature controllable nuclear fusion device and method, and belongs to the field of nuclear energy. The method is characterized in that main substances for nuclear fusion are polyatomic molecules, namely lithium deuteride 6, lithium deuteride 7 and beryllium 9, and a specific method for controlling the intensity of nuclear fusion reaction is provided. According to the technology, after neutrons are generated, a neutron proliferation reaction and a self-circulation continuous nuclear fusion reaction are formed. The main reaction is as follows: firstly, deuterons react with one another to generate neutrons, then the neutrons react with a lithium 6 nucleus d to generate a tritium nucleus t, the t reacts with a lithium 7 nucleus, the neutrons react with a beryllium 9 nucleus, and finally, two neutrons and two helium-4 nucleuses are released. In these processes, nuclear energy is released. In the nuclear fusion reaction, no radioactive daughter nucleus is generated; and incident ion energy is low, nuclear energy is easier to release, efficiency is higher, the structure is simple, and manufacturing cost is low.

2. 发明公开

EP4163930A2 DEVICE AND METHOD FOR THIRD LOW-TEMPERATURE CONTROLLABLE NUCLEAR FUSION 审中-实审
公开(公告)号：EP4163930A2
公开(公告)日：2023-04-12
申请号：EP22195304.5
申请日：2022-09-13
申请人： Chen, Shihao
发明人： CHEN, Yuxing , CHEN, Ziwei , JIANG, Yunpeng , CHEN, Suzhen , CHEN, Shihao
IPC分类号： G21B3/00
摘要： A device and method for third low-temperature controllable nuclear fusion is disclosed. The main substances used for nuclear fusion in the disclosure are polyatomic molecules, namely lithium deuteride 6, lithium deuteride 7 and beryllium 9, and a specific method for controlling the intensity of nuclear fusion reaction is provided. After neutrons are generated, a neutron proliferation reaction and a self-circulation continuous nuclear fusion reaction are formed. The main reaction is as follows: firstly, deuterons react with one another to generate neutrons, then the neutrons react with a lithium-6 nucleus d to generate a tritium nucleus t, the t reacts with a lithium-7 nucleus, the neutrons react with a beryllium-9 nucleus, and finally, two neutrons and two helium-4 nucleuses are released.

3. 发明公开

EP4163930A3 DEVICE AND METHOD FOR THIRD LOW-TEMPERATURE CONTROLLABLE NUCLEAR FUSION 审中-实审
公开(公告)号：EP4163930A3
公开(公告)日：2023-06-14
申请号：EP22195304.5
申请日：2022-09-13
申请人： Chen, Shihao
发明人： CHEN, Yuxing , CHEN, Ziwei , JIANG, Yunpeng , CHEN, Suzhen , CHEN, Shihao
IPC分类号： G21B3/00
摘要： A device and method for third low-temperature controllable nuclear fusion is disclosed. The main substances used for nuclear fusion in the disclosure are polyatomic molecules, namely lithium deuteride 6, lithium deuteride 7 and beryllium 9, and a specific method for controlling the intensity of nuclear fusion reaction is provided. After neutrons are generated, a neutron proliferation reaction and a self-circulation continuous nuclear fusion reaction are formed. The main reaction is as follows: firstly, deuterons react with one another to generate neutrons, then the neutrons react with a lithium-6 nucleus d to generate a tritium nucleus t, the t reacts with a lithium-7 nucleus, the neutrons react with a beryllium-9 nucleus, and finally, two neutrons and two helium-4 nucleuses are released.

4. 发明申请

WO2016205277A1 PD-L1 ANTAGONIST COMBINATION TREATMENTS 审中-公开
标题翻译： PD-L1拮抗剂组合治疗
公开(公告)号：WO2016205277A1
公开(公告)日：2016-12-22
申请号：PCT/US2016/037498
申请日：2016-06-15
申请人： MERCK PATENT GMBH , PFIZER, INC. , ANDREWS, Glen Ian , CHEN, Shihao , DI PIETRO, Alessandra , FONTANA, David , GOLDBERG, Zelanna , LIN, Chia-Yang , LONG, Hua , MARTIGNONI, Marcella , NUYTEN, Dimitry Serge Antoine , THALL, Aron David , WOOLFSON, Adrian
发明人： ANDREWS, Glen Ian , CHEN, Shihao , DI PIETRO, Alessandra , FONTANA, David , GOLDBERG, Zelanna , LIN, Chia-Yang , LONG, Hua , MARTIGNONI, Marcella , NUYTEN, Dimitry Serge Antoine , THALL, Aron David , WOOLFSON, Adrian
IPC分类号： C07K16/24 , C07K16/28 , A61P35/00 , A61K31/4439 , A61K39/00
CPC分类号： A61K39/3955 , A61K31/4184 , A61K31/4439 , A61K31/706 , A61K33/24 , A61K39/39558 , A61K45/06 , A61K2039/505 , A61K2039/507 , A61P35/00 , C07K16/243 , C07K16/2827 , C07K16/2878 , C07K16/2887 , C07K2317/21 , C07K2317/76 , A61K2300/00
摘要： The present disclosure describes combination therapies comprising an antagonist of Programmed Death Ligand 1 receptor (PD-L1) and another therapeutic agent, and the use of the combination therapies for the treatment of cancer.
摘要翻译：本公开描述了包含程序性死亡配体1受体（PD-L1）拮抗剂和另一种治疗剂的组合疗法，以及组合疗法用于治疗癌症的组合疗法。

你已经成功收藏专利！

检索式保存成功!

IPRDB